Two daptomycin (DAP) regimens were evaluated in a pharmacokinetic/pharmacodynamic (PK/PD) model, and the mutants recovered were examined for changes in phenotypic characteristics. Three Enterococcus faecium strains (vancomycin-resistant Enterococcus [VRE] ATCC 51559, VRE 12311, and VRE SF 12047) were utilized in a 7-day, 1-compartment in vitro PK/PD model. The simulated dosing regimens were DAP at 6 mg/kg/day (free Cmax [fCmax] = 7.9 μg/ml, half-life [t1/2] = 8 h) and DAP at 10 mg/kg/day (fCmax = 13.17 μg/ml, t1/2 = 8 h). Samples were plated daily on Mueller-Hinton agar containing DAP at 16 μg/ml and 50 mg/liter Ca2+ to assess the emergence of DAP resistance. For each strain, the mutant with the highest DAP MIC was then evaluated for change...
<div><p>Development of <i>in vivo</i> daptomycin resistance (DAP-R) among <i>Staphylococcus aureus</...
Cell wall thickening is a common feature among daptomycin-resistant Staphylococcus aureus strains. H...
The extensive use of daptomycin for treating complex methicillin-resistant Staphylococcus aureus inf...
Two daptomycin (DAP) regimens were evaluated in a pharmacokinetic/pharmacodynamic (PK/PD) model, and...
This is the published version.Daptomycin is used off-label for enterococcal infections; however, dos...
The therapeutic activity of daptomycin was compared with that of vancomycin in a rat model of subcut...
We have previously reported the establishment of a Staphylococcus aureus laboratory strain, 10*3d1, ...
Daptomycin MICs for enterococci are typically 1- to 2-fold higher than those for Staphylococcus aure...
Treatment of multidrug-resistant enterococci has become a challenging clinical problem in hospitals ...
Development of in vivo daptomycin resistance (DAP-R) among Staphylococcus aureus clinical isolates, ...
Increasingly frequent reports have described the in vivo loss of daptomycin susceptibility in associ...
Daptomycin (DAP) is a lipopeptide antibiotic frequently used as a last-resort antibiotic against v...
Enterococcus is one of the most important multi-drug resistant nosocomial pathogens. Infections caus...
ABSTRACT Treatment of multidrug-resistant enterococci has become a challenging clinical problem in h...
A patient developed a daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) infect...
<div><p>Development of <i>in vivo</i> daptomycin resistance (DAP-R) among <i>Staphylococcus aureus</...
Cell wall thickening is a common feature among daptomycin-resistant Staphylococcus aureus strains. H...
The extensive use of daptomycin for treating complex methicillin-resistant Staphylococcus aureus inf...
Two daptomycin (DAP) regimens were evaluated in a pharmacokinetic/pharmacodynamic (PK/PD) model, and...
This is the published version.Daptomycin is used off-label for enterococcal infections; however, dos...
The therapeutic activity of daptomycin was compared with that of vancomycin in a rat model of subcut...
We have previously reported the establishment of a Staphylococcus aureus laboratory strain, 10*3d1, ...
Daptomycin MICs for enterococci are typically 1- to 2-fold higher than those for Staphylococcus aure...
Treatment of multidrug-resistant enterococci has become a challenging clinical problem in hospitals ...
Development of in vivo daptomycin resistance (DAP-R) among Staphylococcus aureus clinical isolates, ...
Increasingly frequent reports have described the in vivo loss of daptomycin susceptibility in associ...
Daptomycin (DAP) is a lipopeptide antibiotic frequently used as a last-resort antibiotic against v...
Enterococcus is one of the most important multi-drug resistant nosocomial pathogens. Infections caus...
ABSTRACT Treatment of multidrug-resistant enterococci has become a challenging clinical problem in h...
A patient developed a daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) infect...
<div><p>Development of <i>in vivo</i> daptomycin resistance (DAP-R) among <i>Staphylococcus aureus</...
Cell wall thickening is a common feature among daptomycin-resistant Staphylococcus aureus strains. H...
The extensive use of daptomycin for treating complex methicillin-resistant Staphylococcus aureus inf...